Vaxcyte EBIT 2019-2024 | PCVX

Vaxcyte EBIT for the quarter ending September 30, 2024 was $-0.140B, a 23.8% increase year-over-year.

  • Vaxcyte 2023 EBIT was -0.468B, a 101.52% increase from 2022.
  • Vaxcyte 2022 EBIT was -0.232B, a 124.03% increase from 2021.
  • Vaxcyte 2021 EBIT was -0.104B, a 15.73% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Vaxcyte EBIT 2019-2024 | PCVX

  • Vaxcyte 2023 EBIT was -0.468B, a 101.52% increase from 2022.
  • Vaxcyte 2022 EBIT was -0.232B, a 124.03% increase from 2021.
  • Vaxcyte 2021 EBIT was -0.104B, a 15.73% increase from 2020.

EBIT can be defined as earnings before interest and taxes.